Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rhythm Biosciences Ltd. (AU:RHY)
ASX:RHY
Rhythm Biosciences Ltd. (RHY) Share Price & Analysis
2 Followers
RHY Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.09 - AU$0.81
Previous CloseAU$0.09
Volume3.00
Average Volume (3M)189.00K
Market Cap
AU$22.63M
Enterprise ValueAU$15.21M
Total Cash (Recent Filing)AU$7.60M
Total Debt (Recent Filing)AU$170.14K
Price to Earnings (P/E)-2.4
Beta0.96
Next Earnings
Aug 29, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares OutstandingN/A
10 Day Avg. Volume2,076,771
30 Day Avg. Volume189,005
Standard Deviation0.38
R-Squared0.14
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
18.54% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
81.46% Public Companies and
Individual Investors
RHY FAQ
What was Rhythm Biosciences Ltd.’s price range in the past 12 months?
Rhythm Biosciences Ltd. lowest share price was AU$0.09 and its highest was AU$0.81 in the past 12 months.
What is Rhythm Biosciences Ltd.’s market cap?
Currently, no data Available
When is Rhythm Biosciences Ltd.’s upcoming earnings report date?
Rhythm Biosciences Ltd.’s upcoming earnings report date is Aug 29, 2024 which is in 124 days.
How were Rhythm Biosciences Ltd.’s earnings last quarter?
Rhythm Biosciences Ltd. released its earnings results on Feb 28, 2024. The company reported -AU$0.018 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.018.
Is Rhythm Biosciences Ltd. overvalued?
According to Wall Street analysts Rhythm Biosciences Ltd.’s price is currently Overvalued.
Does Rhythm Biosciences Ltd. pay dividends?
Rhythm Biosciences Ltd. does not currently pay dividends.
What is Rhythm Biosciences Ltd.’s EPS estimate?
Rhythm Biosciences Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rhythm Biosciences Ltd. have?
Rhythm Biosciences Ltd. has 245,982,060 shares outstanding.
What happened to Rhythm Biosciences Ltd.’s price movement after its last earnings report?
Rhythm Biosciences Ltd. reported an EPS of -AU$0.018 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Rhythm Biosciences Ltd.?
Currently, no hedge funds are holding shares in AU:RHY
---
Rhythm Biosciences Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:RHY Sentiment 75%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth AU$1.1M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-80.38%
12-Months-Change
Fundamentals
Return on Equity
-171.97%
Trailing 12-Months
Asset Growth
-80.64%
Trailing 12-Months
Company Description
Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.
---
Technical Analysis
Regeneus Ltd.
―
Apiam Animal Health Ltd.
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
---